BioCatalystWatch
TARAWorkspace / TARA / OverviewCompany library
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc.

Protara Therapeutics, Inc. (TARA)

Website

Price
Market cap
Next catalystExpected Q4 2026IV Choline Chloride — THRIVE-3 · Phase 2/3 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

IV Choline Chloride

PreINDP1P2FilingApproved
Upcoming / outlook

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

IV Choline Chloride

PreINDP1P2FilingApproved
Upcoming / outlook

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved

Other pipelines

IV Choline Chloride

PreINDP1P2P3FilingApproved
TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved
TARA-002

Cell therapy

TLR2 × NOD2

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TARA PR & News

PR & News

TARA SEC archive